These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 8913662)

  • 1. Anticardiolipin antibodies in acute rheumatic fever and chronic rheumatic heart disease: is there a significant association?
    Narin N; Kütükçüler N; Narin F; Keser G; Doganavsargil E
    Clin Exp Rheumatol; 1996; 14(5):567-9. PubMed ID: 8913662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of IgG specific antimyosin antibodies in acute rheumatic fever (ARF): differential profiles of antibodies to myosin and soluble myocardial antigens in ARF, acute glomerulonephritis and group A streptococcal pharyngitis.
    Jambotkar SM; Shastry P; Kamat JR; Kinare SG
    J Clin Lab Immunol; 1993; 40(4):149-61. PubMed ID: 7707341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticardiolipin antibodies are not associated with rheumatic heart disease.
    Ilarraza H; Márquez MF; Alcocer A; Bañales JL; Nava AH; Reyes PA
    Lupus; 2001; 10(12):873-5. PubMed ID: 11787877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistence of heart reactive antibodies (HRA) in acute rheumatic fever (ARF) and rheumatic heart disease (RHD) patients.
    Shastry P; Naik S; Joshi M; Kinare S
    J Clin Lab Immunol; 1988 Oct; 27(2):87-90. PubMed ID: 3246685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of IL-1, IL-2 production and IL-2 receptor generation in patients with acute rheumatic fever and active rheumatic heart disease; a prospective study.
    Morris K; Mohan C; Wahi PL; Anand IS; Ganguly NK
    Clin Exp Immunol; 1993 Mar; 91(3):429-36. PubMed ID: 8095193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticardiolipin antibodies in acute rheumatic fever.
    Figueroa F; Berríos X; Gutiérrez M; Carrión F; Goycolea JP; Riedel I; Jacobelli S
    J Rheumatol; 1992 Aug; 19(8):1175-80. PubMed ID: 1365552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma interleukin-7 (IL-7) and IL-8 concentrations in acute rheumatic fever and chronic rheumatic heart disease.
    Kütükçüler N; Narin N
    Scand J Rheumatol; 1995; 24(6):383-5. PubMed ID: 8610224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticardiolipin antibodies, rheumatic fever and rheumatic heart disease.
    Reyes PA; Amigo MC; Bañales JL; Nava A
    J Rheumatol; 1994 Dec; 21(12):2389. PubMed ID: 7755767
    [No Abstract]   [Full Text] [Related]  

  • 9. Superantigen-induced T cell responses in acute rheumatic fever and chronic rheumatic heart disease patients.
    Bhatnagar A; Grover A; Ganguly NK
    Clin Exp Immunol; 1999 Apr; 116(1):100-6. PubMed ID: 10209512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to N-acetylglucosamine and heparin in acute and remission phases of rheumatic fever.
    Shastry P; Iyer SV; Jambotkar SM; Kandoth PW; Kinare SG
    J Clin Lab Immunol; 1991 Jun; 35(2):65-9. PubMed ID: 1668760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheumatic fever and chronic rheumatic heart disease in Yarrabah aboriginal community, north Queensland. Establishment of a prophylactic program.
    Neilson G; Streatfield RW; West M; Johnson S; Glavin W; Baird S
    Med J Aust; 1993 Mar; 158(5):316-8. PubMed ID: 8474371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of antibodies to muramyl dipeptide, the adjuvant moiety of streptococcal cell wall, in patients with rheumatic fever.
    Bahr GM; Majeed HA; Yousof AM; Chedid L; Behbehani K
    J Infect Dis; 1986 Dec; 154(6):1012-7. PubMed ID: 3782865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral blood T & B lymphocytes during acute rheumatic fever, rheumatic heart disease & streptococcal pharyngitis.
    Prakash K; Bhatnagar PK; Sharma KB
    Indian J Med Res; 1983 Jul; 78():1-6. PubMed ID: 6605919
    [No Abstract]   [Full Text] [Related]  

  • 14. Lymphocyte subsets in acute rheumatic fever and rheumatic heart disease.
    Bhatia R; Narula J; Reddy KS; Koicha M; Malaviya AN; Pothineni RB; Tandon R; Bhatia ML
    Clin Cardiol; 1989 Jan; 12(1):34-8. PubMed ID: 2912606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of antibody responses to streptococcal and tissue antigens in patients with acute rheumatic fever.
    Martins TB; Hoffman JL; Augustine NH; Phansalkar AR; Fischetti VA; Zabriskie JB; Cleary PP; Musser JM; Veasy LG; Hill HR
    Int Immunol; 2008 Mar; 20(3):445-52. PubMed ID: 18245783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of anticardiolipin antibodies in patient cohorts with distinct clinical manifestations of the antiphospholipid syndrome.
    Damoiseaux J; Peeters L; Hupperts R; Boreas A; ten Cate H; Tervaert JW
    Ann N Y Acad Sci; 2009 Sep; 1173():146-51. PubMed ID: 19758143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An important investment to control Acute Rheumatic Fever needs to run its course.
    Lennon D; Stewart J
    N Z Med J; 2015 Jun; 128(1416):6-9. PubMed ID: 26117670
    [No Abstract]   [Full Text] [Related]  

  • 18. [Complications of streptococcal angina].
    Dachy A
    Brux Med; 1973 Nov; 53(11):637-41. PubMed ID: 4769200
    [No Abstract]   [Full Text] [Related]  

  • 19. Lymphocyte subsets and plasma IL-1 alpha, IL-2, and TNF-alpha concentrations in acute rheumatic fever and chronic rheumatic heart disease.
    Narin N; Kütükçüler N; Ozyürek R; Bakiler AR; Parlar A; Arcasoy M
    Clin Immunol Immunopathol; 1995 Nov; 77(2):172-6. PubMed ID: 7586724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunologic mechanisms in the chronic phase of rheumatic disease].
    Fantini F
    Minerva Med; 1972 May; 63(41):2307-10. PubMed ID: 4537366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.